Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by muscle weakness and fatigue, typically resulting from antibodies targeting the acetylcholine receptors (AChR) at the neuromuscular junction. Treatment of MG primarily involves the use of medications aimed at improving neuromuscular transmission and reducing symptoms. Here’s a detailed note covering the …
DeepakRajput 
High-Risk Drugs: Understanding, Management, and Mitigation
Definition: High-risk drugs are medications that have a higher potential for causing significant harm if used improperly. These drugs often require careful monitoring, specialized administration techniques, and stringent safety protocols due to their inherent risks. Characteristics of High-Risk Drugs 1. Narrow Therapeutic Index (NTI): Drugs with a narrow therapeutic index …
Myasthenia gravis (MG)
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by muscle weakness and fatigue. It results from the production of autoantibodies that target and disrupt the function of acetylcholine receptors at the neuromuscular junction, impairing nerve-to-muscle signal transmission. Classification Medications used in the treatment of myasthenia gravis can be categorized …
